GSK Plc said it won US approval for a drug to treat severe asthma, boosting its prospects as a potential blockbuster.

UK's health regulator on Monday approved GSK's twice-yearly drug for use as an add-on treatment for asthma in patients aged ...

The U.S. health regulator has approved GSK's add-on treatment for severe asthma, offering a less frequently dosed option, but ...

If the FeNO level is not raised, it is recommended that the patient be offered either a Long-Acting Muscarinic Antagonist ...

The MHRA has approved depemokimab as an add on treatment for severe asthma and chronic rhinosinusitis with nasal polyps.

The U.S. health regulator has approved GSK's add-on drug to treat severe asthma, the drugmaker said on Tuesday, paving the ...

Winter woes like blocked noses and breathing trouble for asthma and sinus sufferers may find relief with turmeric. Its potent ...

Phase 3 studies point to sustained disease control in patients who remain symptomatic despite standard therapies.

Allergy shots and drops offer a transformative solution for millions. Major health organisations globally endorse this ...

Pittsburgh Steelers defensive tackle Cameron Heyward was diagnosed with asthma as a child and has had to manage it throughout his Ohio State and NFL football career.

A monthly injection for managing severe asthma could help patients safely reduce or even discontinue daily steroid ...

Exploration of key clinical trial data and real-world evidence on dupilumab in asthma and COPD presented at the ERS and CHEST ...